Seizures following reduction in phenytoin level after orally administered folic acid.
Steinweg
Donald Lee
DL
School of Medicine, University of Virginia, Charlottesville, USA. Dsteinweg@carilion.com
Bentley
Michael L
ML
D000284:Administration, Oral; D000748:Anemia, Macrocytic / Q000139:chemically induced / Q000188:drug therapy*; D000927:Anticonvulsants / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000097:blood; D004305:Dose-Response Relationship, Drug; D015536:Down-Regulation / Q000187:drug effects / Q000502:physiology; D004334:Drug Administration Schedule; D004347:Drug Interactions / Q000502:physiology; D004827:Epilepsy / Q000139:chemically induced* / Q000188:drug therapy / Q000517:prevention & control; D004830:Epilepsy, Tonic-Clonic / Q000139:chemically induced / Q000517:prevention & control; D005492:Folic Acid / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010672:Phenytoin / Q000009:adverse effects / Q000037:antagonists & inhibitors* / Q000097:blood*; D055502:Secondary Prevention
D000927:Anticonvulsants; D010672:Phenytoin; D005492:Folic Acid